Avid Bioservices Inc (CDMO)

[freethemice]

John, I would avoid any more trials for pancreatic cancer. Why risk it? They have good data on bavi's
effectiveness in breast cancer from the two earlier trials so I would pursue that. I think the current
investigator-sponsored trials (ISTs) might give some more clues on other indications. I hope
to see some data from the liver cancer trial this year, and prostate cancer. April 1 is, of course,
April Fools Day, which is why I chose it, because I think it is a fool's errand to predict stock prices,
or pretty much anything else! All I can say is that I still have a strong feeling about the science
behind the anti-PS approach to cancer immunotherapy.